nodes	percent_of_prediction	percent_of_DWPC	metapath
Tapentadol—SLC6A2—sympathetic nervous system—metabolic syndrome X	0.023	0.308	CbGeAlD
Tapentadol—SLC6A2—autonomic nervous system—metabolic syndrome X	0.0154	0.207	CbGeAlD
Tapentadol—Lethargy—Metformin—metabolic syndrome X	0.00906	0.0383	CcSEcCtD
Tapentadol—Breast disorder—Metformin—metabolic syndrome X	0.00802	0.0339	CcSEcCtD
Tapentadol—Nasopharyngitis—Metformin—metabolic syndrome X	0.00794	0.0336	CcSEcCtD
Tapentadol—UGT1A9—kidney—metabolic syndrome X	0.00754	0.101	CbGeAlD
Tapentadol—Abdominal discomfort—Metformin—metabolic syndrome X	0.00736	0.0311	CcSEcCtD
Tapentadol—Upper respiratory tract infection—Metformin—metabolic syndrome X	0.00713	0.0302	CcSEcCtD
Tapentadol—Infestation—Metformin—metabolic syndrome X	0.00684	0.0289	CcSEcCtD
Tapentadol—Infestation NOS—Metformin—metabolic syndrome X	0.00684	0.0289	CcSEcCtD
Tapentadol—Bradycardia—Metformin—metabolic syndrome X	0.00625	0.0264	CcSEcCtD
Tapentadol—Hypoaesthesia—Metformin—metabolic syndrome X	0.00611	0.0258	CcSEcCtD
Tapentadol—UGT2B7—kidney—metabolic syndrome X	0.00608	0.0815	CbGeAlD
Tapentadol—Connective tissue disorder—Metformin—metabolic syndrome X	0.00604	0.0255	CcSEcCtD
Tapentadol—OPRD1—kidney—metabolic syndrome X	0.00596	0.0799	CbGeAlD
Tapentadol—Eye disorder—Metformin—metabolic syndrome X	0.00574	0.0243	CcSEcCtD
Tapentadol—Cardiac disorder—Metformin—metabolic syndrome X	0.0057	0.0241	CcSEcCtD
Tapentadol—Angiopathy—Metformin—metabolic syndrome X	0.00557	0.0236	CcSEcCtD
Tapentadol—Immune system disorder—Metformin—metabolic syndrome X	0.00555	0.0235	CcSEcCtD
Tapentadol—Mediastinal disorder—Metformin—metabolic syndrome X	0.00554	0.0234	CcSEcCtD
Tapentadol—Chills—Metformin—metabolic syndrome X	0.00551	0.0233	CcSEcCtD
Tapentadol—Malnutrition—Metformin—metabolic syndrome X	0.00535	0.0226	CcSEcCtD
Tapentadol—Vision blurred—Metformin—metabolic syndrome X	0.00504	0.0213	CcSEcCtD
Tapentadol—Tremor—Metformin—metabolic syndrome X	0.00501	0.0212	CcSEcCtD
Tapentadol—Syncope—Metformin—metabolic syndrome X	0.00479	0.0203	CcSEcCtD
Tapentadol—UGT1A9—liver—metabolic syndrome X	0.00477	0.0639	CbGeAlD
Tapentadol—Palpitations—Metformin—metabolic syndrome X	0.00472	0.02	CcSEcCtD
Tapentadol—Loss of consciousness—Metformin—metabolic syndrome X	0.0047	0.0199	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.00452	0.0191	CcSEcCtD
Tapentadol—Oedema—Metformin—metabolic syndrome X	0.00436	0.0185	CcSEcCtD
Tapentadol—Infection—Metformin—metabolic syndrome X	0.00434	0.0183	CcSEcCtD
Tapentadol—Shock—Metformin—metabolic syndrome X	0.00429	0.0182	CcSEcCtD
Tapentadol—Nervous system disorder—Metformin—metabolic syndrome X	0.00428	0.0181	CcSEcCtD
Tapentadol—Skin disorder—Metformin—metabolic syndrome X	0.00424	0.0179	CcSEcCtD
Tapentadol—Hyperhidrosis—Metformin—metabolic syndrome X	0.00422	0.0178	CcSEcCtD
Tapentadol—Hypotension—Metformin—metabolic syndrome X	0.00408	0.0172	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.00398	0.0168	CcSEcCtD
Tapentadol—Paraesthesia—Metformin—metabolic syndrome X	0.00392	0.0166	CcSEcCtD
Tapentadol—Dyspnoea—Metformin—metabolic syndrome X	0.00389	0.0165	CcSEcCtD
Tapentadol—Somnolence—Metformin—metabolic syndrome X	0.00388	0.0164	CcSEcCtD
Tapentadol—UGT2B7—liver—metabolic syndrome X	0.00384	0.0515	CbGeAlD
Tapentadol—Dyspepsia—Metformin—metabolic syndrome X	0.00384	0.0162	CcSEcCtD
Tapentadol—Decreased appetite—Metformin—metabolic syndrome X	0.00379	0.016	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.00377	0.0159	CcSEcCtD
Tapentadol—Fatigue—Metformin—metabolic syndrome X	0.00376	0.0159	CcSEcCtD
Tapentadol—Constipation—Metformin—metabolic syndrome X	0.00373	0.0158	CcSEcCtD
Tapentadol—Feeling abnormal—Metformin—metabolic syndrome X	0.0036	0.0152	CcSEcCtD
Tapentadol—Urticaria—Metformin—metabolic syndrome X	0.00347	0.0147	CcSEcCtD
Tapentadol—Asthenia—Metformin—metabolic syndrome X	0.00313	0.0132	CcSEcCtD
Tapentadol—Pruritus—Metformin—metabolic syndrome X	0.00309	0.0131	CcSEcCtD
Tapentadol—Diarrhoea—Metformin—metabolic syndrome X	0.00299	0.0126	CcSEcCtD
Tapentadol—Dizziness—Metformin—metabolic syndrome X	0.00289	0.0122	CcSEcCtD
Tapentadol—Vomiting—Metformin—metabolic syndrome X	0.00277	0.0117	CcSEcCtD
Tapentadol—Rash—Metformin—metabolic syndrome X	0.00275	0.0116	CcSEcCtD
Tapentadol—Dermatitis—Metformin—metabolic syndrome X	0.00275	0.0116	CcSEcCtD
Tapentadol—Headache—Metformin—metabolic syndrome X	0.00273	0.0116	CcSEcCtD
Tapentadol—Nausea—Metformin—metabolic syndrome X	0.00259	0.011	CcSEcCtD
Tapentadol—CYP2C9—cardiovascular system—metabolic syndrome X	0.00222	0.0298	CbGeAlD
Tapentadol—CYP2C19—liver—metabolic syndrome X	0.00177	0.0237	CbGeAlD
Tapentadol—CYP2D6—kidney—metabolic syndrome X	0.00163	0.0218	CbGeAlD
Tapentadol—CYP2C9—liver—metabolic syndrome X	0.00137	0.0184	CbGeAlD
Tapentadol—CYP2D6—liver—metabolic syndrome X	0.00103	0.0138	CbGeAlD
Tapentadol—CYP2D6—Metabolism—EPHX2—metabolic syndrome X	0.000257	0.000373	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—MLXIPL—metabolic syndrome X	0.000257	0.000373	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CYBA—metabolic syndrome X	0.000256	0.000371	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—metabolic syndrome X	0.000255	0.000371	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—EPHX2—metabolic syndrome X	0.000255	0.00037	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—MLXIPL—metabolic syndrome X	0.000255	0.00037	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—GHRL—metabolic syndrome X	0.00025	0.000363	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—metabolic syndrome X	0.00025	0.000362	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—APOC3—metabolic syndrome X	0.000247	0.000359	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—CCL2—metabolic syndrome X	0.000244	0.000355	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—AGT—metabolic syndrome X	0.000242	0.000351	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—metabolic syndrome X	0.000242	0.000351	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—G6PC2—metabolic syndrome X	0.000242	0.000351	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—G6PC2—metabolic syndrome X	0.000239	0.000348	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	0.000239	0.000347	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—APOB—metabolic syndrome X	0.000239	0.000347	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CNR1—metabolic syndrome X	0.000237	0.000344	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—ABCA1—metabolic syndrome X	0.000237	0.000343	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—SLC2A4—metabolic syndrome X	0.000237	0.000343	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—PLA2G4A—metabolic syndrome X	0.000233	0.000338	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—GGT1—metabolic syndrome X	0.000229	0.000333	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—GOT1—metabolic syndrome X	0.000229	0.000333	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—LPL—metabolic syndrome X	0.000228	0.000332	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—metabolic syndrome X	0.000228	0.00033	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—FABP4—metabolic syndrome X	0.000223	0.000324	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—HTR2C—metabolic syndrome X	0.000223	0.000324	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—IGF2—metabolic syndrome X	0.000221	0.000321	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—metabolic syndrome X	0.00022	0.00032	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—AGT—metabolic syndrome X	0.00022	0.000319	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—CD36—metabolic syndrome X	0.000217	0.000315	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CYBA—metabolic syndrome X	0.000216	0.000314	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—APOB—metabolic syndrome X	0.000214	0.000311	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—CCL2—metabolic syndrome X	0.000214	0.000311	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—HSD11B1—metabolic syndrome X	0.000212	0.000307	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—GHRL—metabolic syndrome X	0.000211	0.000307	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CCL5—metabolic syndrome X	0.000209	0.000304	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000209	0.000303	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—FABP4—metabolic syndrome X	0.000205	0.000298	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—APOB—metabolic syndrome X	0.000205	0.000298	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—LPL—metabolic syndrome X	0.000205	0.000297	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—FABP4—metabolic syndrome X	0.000204	0.000295	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—PPARA—metabolic syndrome X	0.000202	0.000293	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CNR1—metabolic syndrome X	0.0002	0.000291	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—metabolic syndrome X	0.0002	0.00029	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—LPL—metabolic syndrome X	0.000196	0.000284	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—AGT—metabolic syndrome X	0.000195	0.000284	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—HSD11B1—metabolic syndrome X	0.000195	0.000283	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—APOB—metabolic syndrome X	0.000194	0.000282	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—IGF2—metabolic syndrome X	0.000194	0.000281	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—HSD11B1—metabolic syndrome X	0.000193	0.00028	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—APOE—metabolic syndrome X	0.000191	0.000278	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—APOA1—metabolic syndrome X	0.000189	0.000275	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—PLA2G4A—metabolic syndrome X	0.000189	0.000274	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—G6PD—metabolic syndrome X	0.000189	0.000274	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—APOB—metabolic syndrome X	0.000188	0.000273	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—APOB—metabolic syndrome X	0.000187	0.000272	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—CD36—metabolic syndrome X	0.000186	0.00027	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—LPL—metabolic syndrome X	0.000186	0.000269	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—HDAC3—metabolic syndrome X	0.000184	0.000267	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CCL5—metabolic syndrome X	0.000184	0.000267	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000183	0.000266	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—metabolic syndrome X	0.000182	0.000264	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—CCL2—metabolic syndrome X	0.000181	0.000263	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—GCKR—metabolic syndrome X	0.00018	0.000261	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—LPA—metabolic syndrome X	0.00018	0.000261	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—LPL—metabolic syndrome X	0.00018	0.000261	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—LPL—metabolic syndrome X	0.000179	0.000259	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—CD36—metabolic syndrome X	0.000176	0.000256	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—AGT—metabolic syndrome X	0.000175	0.000254	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PLA2G6—metabolic syndrome X	0.000174	0.000253	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—G6PD—metabolic syndrome X	0.000174	0.000252	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	0.000173	0.000251	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—APOA5—metabolic syndrome X	0.000173	0.00025	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—G6PD—metabolic syndrome X	0.000172	0.00025	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—APOE—metabolic syndrome X	0.000172	0.000249	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—LEP—metabolic syndrome X	0.000172	0.000249	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—CD36—metabolic syndrome X	0.00017	0.000246	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—APOA1—metabolic syndrome X	0.00017	0.000246	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—HDAC3—metabolic syndrome X	0.000169	0.000246	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—HDAC3—metabolic syndrome X	0.000168	0.000244	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	0.000168	0.000243	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—PPARG—metabolic syndrome X	0.000167	0.000242	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—GCKR—metabolic syndrome X	0.000166	0.00024	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—LPA—metabolic syndrome X	0.000166	0.00024	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	0.000164	0.000238	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—LPA—metabolic syndrome X	0.000164	0.000238	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—GCKR—metabolic syndrome X	0.000164	0.000238	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—PPARA—metabolic syndrome X	0.000164	0.000238	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—IGF2—metabolic syndrome X	0.000164	0.000238	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—INS—metabolic syndrome X	0.000164	0.000237	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	0.000162	0.000236	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—TRIB3—metabolic syndrome X	0.00016	0.000233	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PLA2G6—metabolic syndrome X	0.00016	0.000233	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—APOB—metabolic syndrome X	0.000159	0.000231	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PLA2G6—metabolic syndrome X	0.000159	0.000231	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—AGT—metabolic syndrome X	0.000159	0.000231	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—APOA5—metabolic syndrome X	0.000159	0.00023	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	0.000158	0.000229	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—APOA5—metabolic syndrome X	0.000157	0.000228	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—APOE—metabolic syndrome X	0.000156	0.000226	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CCL5—metabolic syndrome X	0.000155	0.000225	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000155	0.000224	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—APOA1—metabolic syndrome X	0.000154	0.000223	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—AGT—metabolic syndrome X	0.000154	0.000223	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—IRS1—metabolic syndrome X	0.000153	0.000222	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	0.000153	0.000222	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—LPL—metabolic syndrome X	0.000152	0.00022	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—LEP—metabolic syndrome X	0.000151	0.000219	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—APOE—metabolic syndrome X	0.000151	0.000219	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—ALB—metabolic syndrome X	0.00015	0.000218	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	0.00015	0.000217	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—APOA1—metabolic syndrome X	0.000149	0.000216	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	0.000148	0.000215	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—TRIB3—metabolic syndrome X	0.000148	0.000214	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—INS—metabolic syndrome X	0.000147	0.000213	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—TRIB3—metabolic syndrome X	0.000146	0.000212	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CCL2—metabolic syndrome X	0.000144	0.000209	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—NAMPT—metabolic syndrome X	0.000144	0.000209	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—NOS3—metabolic syndrome X	0.000143	0.000208	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	0.000143	0.000208	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—LIPC—metabolic syndrome X	0.000143	0.000208	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—GCK—metabolic syndrome X	0.000143	0.000208	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—APOC3—metabolic syndrome X	0.000142	0.000206	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—IGF1—metabolic syndrome X	0.000142	0.000206	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—CETP—metabolic syndrome X	0.000138	0.0002	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—PPARG—metabolic syndrome X	0.000136	0.000197	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—SERPINE1—metabolic syndrome X	0.000135	0.000196	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—IRS1—metabolic syndrome X	0.000134	0.000195	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—INS—metabolic syndrome X	0.000133	0.000193	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—NAMPT—metabolic syndrome X	0.000132	0.000192	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—SCARB1—metabolic syndrome X	0.000132	0.000192	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—GCK—metabolic syndrome X	0.000131	0.000191	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—LIPC—metabolic syndrome X	0.000131	0.000191	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—PTGS2—metabolic syndrome X	0.000131	0.00019	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—NAMPT—metabolic syndrome X	0.000131	0.00019	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—APOC3—metabolic syndrome X	0.000131	0.00019	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	0.00013	0.000189	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—GCK—metabolic syndrome X	0.00013	0.000189	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—LIPC—metabolic syndrome X	0.00013	0.000189	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—AGT—metabolic syndrome X	0.00013	0.000188	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—APOC3—metabolic syndrome X	0.00013	0.000188	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—NOS3—metabolic syndrome X	0.000129	0.000187	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	0.000129	0.000187	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—INS—metabolic syndrome X	0.000129	0.000187	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—SREBF1—metabolic syndrome X	0.000128	0.000186	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—LEP—metabolic syndrome X	0.000127	0.000185	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—APOE—metabolic syndrome X	0.000127	0.000185	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—CETP—metabolic syndrome X	0.000127	0.000184	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CCL2—metabolic syndrome X	0.000127	0.000184	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—CETP—metabolic syndrome X	0.000126	0.000183	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—APOA1—metabolic syndrome X	0.000126	0.000183	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—HMGCR—metabolic syndrome X	0.000125	0.000181	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—GOT2—metabolic syndrome X	0.000125	0.000181	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—IGF1—metabolic syndrome X	0.000124	0.000181	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—ALB—metabolic syndrome X	0.000122	0.000177	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—SCARB1—metabolic syndrome X	0.000121	0.000176	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—SCARB1—metabolic syndrome X	0.00012	0.000175	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—SERPINE1—metabolic syndrome X	0.000118	0.000171	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—SREBF1—metabolic syndrome X	0.000118	0.000171	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	0.000117	0.00017	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—SREBF1—metabolic syndrome X	0.000117	0.00017	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—NOS3—metabolic syndrome X	0.000117	0.000169	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—GOT2—metabolic syndrome X	0.000115	0.000167	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—HMGCR—metabolic syndrome X	0.000115	0.000167	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—HMGCR—metabolic syndrome X	0.000114	0.000165	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—GOT2—metabolic syndrome X	0.000114	0.000165	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—IRS1—metabolic syndrome X	0.000113	0.000165	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—NOS3—metabolic syndrome X	0.000113	0.000164	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	0.000113	0.000163	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—ABCA1—metabolic syndrome X	0.000111	0.000161	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—SLC2A4—metabolic syndrome X	0.000111	0.000161	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—AKT1—metabolic syndrome X	0.00011	0.00016	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—INS—metabolic syndrome X	0.000109	0.000158	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—IL6—metabolic syndrome X	0.000108	0.000157	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—GGT1—metabolic syndrome X	0.000108	0.000156	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—GOT1—metabolic syndrome X	0.000108	0.000156	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CCL2—metabolic syndrome X	0.000107	0.000155	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—PTGS2—metabolic syndrome X	0.000107	0.000155	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—IGF1—metabolic syndrome X	0.000105	0.000153	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	0.000103	0.000149	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—ABCA1—metabolic syndrome X	0.000102	0.000148	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—SLC2A4—metabolic syndrome X	0.000102	0.000148	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—ABCA1—metabolic syndrome X	0.000101	0.000147	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—SLC2A4—metabolic syndrome X	0.000101	0.000147	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—AKT1—metabolic syndrome X	0.0001	0.000145	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—SERPINE1—metabolic syndrome X	9.98e-05	0.000145	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—GGT1—metabolic syndrome X	9.9e-05	0.000144	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—GOT1—metabolic syndrome X	9.9e-05	0.000144	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—GGT1—metabolic syndrome X	9.82e-05	0.000143	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—GOT1—metabolic syndrome X	9.82e-05	0.000143	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—AKT1—metabolic syndrome X	9.66e-05	0.00014	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—NOS3—metabolic syndrome X	9.53e-05	0.000138	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—IL6—metabolic syndrome X	9.51e-05	0.000138	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—APOB—metabolic syndrome X	9.14e-05	0.000133	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PLA2G4A—metabolic syndrome X	8.89e-05	0.000129	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—AKT1—metabolic syndrome X	8.78e-05	0.000127	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—LPL—metabolic syndrome X	8.72e-05	0.000127	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—TGFB1—metabolic syndrome X	8.5e-05	0.000123	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—APOB—metabolic syndrome X	8.4e-05	0.000122	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—APOB—metabolic syndrome X	8.33e-05	0.000121	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—CD36—metabolic syndrome X	8.29e-05	0.00012	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PLA2G4A—metabolic syndrome X	8.17e-05	0.000119	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—AKT1—metabolic syndrome X	8.17e-05	0.000119	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PLA2G4A—metabolic syndrome X	8.1e-05	0.000118	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—IL6—metabolic syndrome X	8.04e-05	0.000117	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—LPL—metabolic syndrome X	8.02e-05	0.000116	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—LPL—metabolic syndrome X	7.95e-05	0.000115	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PPARA—metabolic syndrome X	7.71e-05	0.000112	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—CD36—metabolic syndrome X	7.62e-05	0.000111	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—CD36—metabolic syndrome X	7.56e-05	0.00011	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—AGT—metabolic syndrome X	7.46e-05	0.000108	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—TGFB1—metabolic syndrome X	7.46e-05	0.000108	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—AKT1—metabolic syndrome X	7.42e-05	0.000108	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—APOE—metabolic syndrome X	7.31e-05	0.000106	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—APOA1—metabolic syndrome X	7.23e-05	0.000105	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PPARA—metabolic syndrome X	7.09e-05	0.000103	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PPARA—metabolic syndrome X	7.03e-05	0.000102	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—AGT—metabolic syndrome X	6.86e-05	9.96e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—AGT—metabolic syndrome X	6.81e-05	9.88e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—APOE—metabolic syndrome X	6.73e-05	9.76e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—APOE—metabolic syndrome X	6.67e-05	9.68e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—APOA1—metabolic syndrome X	6.65e-05	9.65e-05	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—AKT1—metabolic syndrome X	6.59e-05	9.57e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—APOA1—metabolic syndrome X	6.59e-05	9.57e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—IL6—metabolic syndrome X	6.41e-05	9.3e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PPARG—metabolic syndrome X	6.37e-05	9.25e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—TGFB1—metabolic syndrome X	6.3e-05	9.15e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—INS—metabolic syndrome X	6.25e-05	9.07e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—AKT1—metabolic syndrome X	5.91e-05	8.58e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PPARG—metabolic syndrome X	5.86e-05	8.5e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PPARG—metabolic syndrome X	5.81e-05	8.43e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—INS—metabolic syndrome X	5.75e-05	8.34e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—ALB—metabolic syndrome X	5.73e-05	8.31e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—INS—metabolic syndrome X	5.7e-05	8.27e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—IL6—metabolic syndrome X	5.62e-05	8.16e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—NOS3—metabolic syndrome X	5.48e-05	7.95e-05	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—AKT1—metabolic syndrome X	5.36e-05	7.78e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—ALB—metabolic syndrome X	5.27e-05	7.65e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—ALB—metabolic syndrome X	5.22e-05	7.58e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—AKT1—metabolic syndrome X	5.18e-05	7.52e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—NOS3—metabolic syndrome X	5.04e-05	7.31e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PTGS2—metabolic syndrome X	5.01e-05	7.27e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—NOS3—metabolic syndrome X	5e-05	7.25e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—IL6—metabolic syndrome X	4.75e-05	6.89e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PTGS2—metabolic syndrome X	4.61e-05	6.69e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PTGS2—metabolic syndrome X	4.57e-05	6.63e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—AKT1—metabolic syndrome X	4.38e-05	6.36e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—AKT1—metabolic syndrome X	2.52e-05	3.66e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—AKT1—metabolic syndrome X	2.32e-05	3.36e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—AKT1—metabolic syndrome X	2.3e-05	3.33e-05	CbGpPWpGaD
